Abstract
Background and Aims: Despite guidelines for dyslipidemia (DLP) management and availability of effective lipid lowering drugs (LLD), one half of CVD patients do not control lipid levels. We analyzed the gender difference in frequency of LLD therapy and lipid control in subjects with cardiometabolic diseases (CMD) in Russian population.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
